Tom 8, Nr 2 (2023)
Wytyczne / stanowisko ekspertów
Opublikowany online: 2023-08-18
Wyświetlenia strony 695
Wyświetlenia/pobrania artykułu 307
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Rekomendacje Polskiego Towarzystwa Ginekologów i Położników, Polskiego Towarzystwa Wakcynologii oraz Polskiego Towarzystwa Medycyny Rodzinnej dotyczące szczepień kobiet planujących ciążę, ciężarnych oraz karmiących

Agnieszka Seremak-Mrozikiewicz1, Aneta Nitsch-Osuch2, Krzysztof Czajkowski3, Krzysztof Drews1, Hubert Huras4, Jarosław Kalinka5, Ernest Kuchar6, Bożena Leszczyńska-Gorzelak7, Agnieszka Mastalerz-Migas8, Małgorzata Świątkowska-Freund9, Mirosław Wielgoś10, Hubert Wolski1, Jacek Wysocki11, Mariusz Zimmer12, Piotr Sieroszewski5
Ginekologia i Perinatologia Praktyczna 2023;8(2):89-103.

Streszczenie

Brak

Artykuł dostępny w formacie PDF

Dodaj do koszyka: 49,00 PLN

Posiadasz dostęp do tego artykułu?

Referencje

  1. Castillo E, Patey A, MacDonald N. Vaccination in pregnancy: Challenges and evidence-based solutions. Best Pract Res Clin Obstet Gynaecol. 2021; 76: 83–95.
  2. Sebghati M, Khalil A. Uptake of vaccination in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2021; 76: 53–65.
  3. Jagielska A. Jasik, Nitsch-Osuch A. Lekarze rodzinni w Polsce wobec szczepienia kobiet w ciąży - podstawy i praktyka. https://www.mp. pl/szczepienia/szczepieniaiszczepionki/grupyryzyka/ciaza/190836, lekarze -rodzinni -w-polsce-wobec-szczepienia-kobiet.
  4. Singh T, Otero CE, Li K, et al. Vaccines for Perinatal and Congenital Infections-How Close Are We? Front Pediatr. 2020; 8: 569.
  5. Etti M, Calvert A, Galiza E, et al. Maternal vaccination: a review of current evidence and recommendations. Am J Obstet Gynecol. 2022; 226(4): 459–474.
  6. Badell ML. Hepatitis B: Time to Evaluate Universal Screening and Vaccination in Pregnancy? Obstet Gynecol. 2022; 139(3): 355–356.
  7. Sandmann F, Jit M, Andrews N, et al. Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis. Vaccine. 2021; 39(32): 4500–4509.
  8. Abdullahi H, Elnahas A, Konje JC. Seasonal influenza during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2021; 258: 235–239.
  9. Nypaver C, Dehlinger C, Carter C. Influenza and Influenza Vaccine: A Review. J Midwifery Womens Health. 2021; 66(1): 45–53.
  10. Gunnes N, Gjessing HK, Bakken IJ, et al. Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort study. Eur J Epidemiol. 2020; 35(4): 371–379.
  11. Adeyanju GC, Engel E, Koch L, et al. Determinants of influenza vaccine hesitancy among pregnant women in Europe: a systematic review. Eur J Med Res. 2021; 26(1): 116.
  12. Jash S, Sharma S. Pathogenic Infections during Pregnancy and the Consequences for Fetal Brain Development. Pathogens. 2022; 11(2).
  13. Raut S, Apte A, Srinivasan M, et al. Determinants of maternal influenza vaccination in the context of low- and middle-income countries: A systematic review. PLoS One. 2022; 17(1): e0262871.
  14. Baïssas T, Boisnard F, Cuesta Esteve I, et al. Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain. BMC Public Health. 2021; 21(1): 2182.
  15. Antczak A, Kuchar E, Nitsch-Osuch A, et al. Stanowisko Ekspertów Ogólnopolskiego Programu Zwalczania Grypy oraz Polskiego Towarzystwa Ginekologów i Położników dotyczące szczepienia przeciw grypie kobiet w ciąży. Ginekologia i Perinatologia Praktyczna. 2020; 5(3): 112–118.
  16. Alhendyani F, Jolly K, Jones LL. Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis. PLoS One. 2022; 17(2): e0263234.
  17. Morales KF, Menning L, Lambach P. The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers' recommendation of influenza vaccine in pregnancy. Vaccine. 2020; 38(31): 4805–4815.
  18. Offeddu V, Tam CC, Yong TT, et al. Coverage and determinants of influenza vaccine among pregnant women: a cross-sectional study. BMC Public Health. 2019; 19(1): 890.
  19. Nitsch-Osuch A, Woźniak Kosek A, Brydak LB. [Vaccination against influenza in pregnant women - safety and effectiveness]. Ginekol Pol. 2013; 84(1): 56–61.
  20. Macias Saint-Gerons D, Solà Arnau I, De Mucio B, et al. Adverse events associated with the use of recommended vaccines during pregnancy: An overview of systematic reviews. Vaccine. 2021; 39 Suppl 2: B12–B26.
  21. Regan AK, Munoz FM. Efficacy and safety of influenza vaccination during pregnancy: realizing the potential of maternal influenza immunization. Expert Rev Vaccines. 2021; 20(6): 649–660.
  22. Lu QC, Zhang TY, Bundhun PK, et al. One "misunderstood" health issue: demonstrating and communicating the safety of influenza a vaccination in pregnancy: a systematic review and meta-analysis. BMC Public Health. 2021; 21(1): 703.
  23. Moro P, Baumblatt J, Lewis P, et al. Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016. Drug Saf. 2017; 40(2): 145–152.
  24. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008; 359(15): 1555–1564.
  25. Benowitz I, Esposito DB, Gracey KD, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 2010; 51(12): 1355–1361.
  26. https://www.ecdc.europa.eu/en/pertussis..
  27. Stefanoff P, Paradowska-Stankiewicz IA, Lipke M, et al. Incidence of pertussis in patients of general practitioners in Poland. Epidemiol Infect. 2014; 142(4): 714–723.
  28. Berbers G, van Gageldonk P, Kassteele Jv, et al. Serosurveillance Study Team. Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries. Nat Commun. 2021; 12(1): 2871.
  29. Tessier E, Campbell H, Ribeiro S, et al. Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014-2018. Clin Infect Dis. 2021; 73(9): e2502–e2508.
  30. Khodr ZG, Bukowinski AT, Gumbs GR, et al. Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections. Vaccine. 2017; 35(42): 5603–5610.
  31. Shakib JH, Korgenski K, Sheng X, et al. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr. 2013; 163(5): 1422–6.e1.
  32. Vygen-Bonnet S, Hellenbrand W, Garbe E, et al. Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review. BMC Infect Dis. 2020; 20(1): 136.
  33. Becerra-Culqui TA, Getahun D, Chiu V, et al. Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination and Autism Spectrum Disorder. Pediatrics. 2018; 142(3).
  34. Becerra-Culqui TA, Getahun D, Chiu V, et al. The Association of Prenatal Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccination With Attention-Deficit/Hyperactivity Disorder. Am J Epidemiol. 2020; 189(10): 1163–1172.
  35. DeSilva M, Vazquez-Benitez G, Nordin JD, et al. Maternal Tdap vaccination and risk of infant morbidity. Vaccine. 2017; 35(29): 3655–3660.
  36. Griffin JB, Yu L, Watson D, et al. Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine. Vaccine. 2018; 36(34): 5173–5179.
  37. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA. 2014; 312(18): 1897–1904.
  38. Layton JB, Butler AM, Li D, et al. Prenatal Tdap immunization and risk of maternal and newborn adverse events. Vaccine. 2017; 35(33): 4072–4078.
  39. Kalafat E, Heath P, Prasad S, et al. COVID-19 vaccination in pregnancy-number needed to vaccinate to avoid harm. Lancet Infect Dis. 2021; 21(12): 1627–147.
  40. Vitiello A, Ferrara F, Zovi A, et al. Pregnancy and COVID-19, focus on vaccine and pharmacological treatment. J Reprod Immunol. 2022; 151: 103630.
  41. Prasad S, Kalafat E, Blakeway H, et al. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. Nat Commun. 2022; 13(1): 2414.
  42. Male V. SARS-CoV-2 infection and COVID-19 vaccination in pregnancy. Nat Rev Immunol. 2022; 22(5): 277–282.
  43. Pietrasanta C, Ronchi A, Crippa BL, et al. Coronavirus Disease 2019 Vaccination During Pregnancy and Breastfeeding: A Review of Evidence and Current Recommendations in Europe, North America, and Australasia. Front Pediatr. 2022; 10: 883953.
  44. Shimabukuro TT, Kim SY, Myers TR, et al. CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med. 2021; 384(24): 2273–2282.
  45. Falsaperla R, Leone G, Familiari M, et al. COVID-19 vaccination in pregnant and lactating women: a systematic review. Expert Rev Vaccines. 2021; 20(12): 1619–1628.
  46. Fu W, Sivajohan B, McClymont E, et al. Systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnant and lactating individuals and their infants. Int J Gynaecol Obstet. 2022; 156(3): 406–417.
  47. Moro PL, Museru OI, Niu M, et al. Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women. Am J Obstet Gynecol. 2014; 210(6): 561.e1–561.e6.
  48. D'Acremont V, Tremblay S, Genton B. Impact of vaccines given during pregnancy on the offspring of women consulting a travel clinic: a longitudinal study. J Travel Med. 2008; 15(2): 77–81.
  49. Prabhu M, Susich MK, Packer CH, et al. Universal Hepatitis B Antibody Screening and Vaccination in Pregnancy: A Cost-Effectiveness Analysis. Obstet Gynecol. 2022; 139(3): 357–367.
  50. Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Hepatitis B vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev. 2011(3): CD007879.
  51. Centers for Disease Control and Prevention. Pregnancy guidelines and recommendations by vaccine. 2016. https://www.cdc. gov/vaccines/pregnancy/hcp-toolkit/guidelines.
  52. Arora M, Lakshmi R. Vaccines - safety in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2021; 76: 23–40.
  53. Zhang Y, Zhang H, Wang B, et al. Pregnancy outcomes after a mass vaccination campaign with an oral cholera vaccine: a systematic review and meta-analysis. BJOG. 2020; 127(9): 1066–1073.
  54. Terracciano E, Amadori F, Pettinicchio V, et al. Strategies for elimination of rubella in pregnancy and of congenital rubella syndrome in high and upper-middle income countries. J Prev Med Hyg. 2020; 61(1): E98–E9E108.
  55. Mangtani P, Evans SJW, Lange B, et al. Safety profile of rubella vaccine administered to pregnant women: A systematic review of pregnancy related adverse events following immunisation, including congenital rubella syndrome and congenital rubella infection in the foetus or infant. Vaccine. 2020; 38(5): 963–978.
  56. Nanthakumar MP, Sood A, Ahmed M, et al. Varicella Zoster in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2021; 258: 283–287.
  57. Gnann JW. Varicella-zoster virus: Prevention through vaccination. Clin Obstet Gynecol. 2012; 55(2): 560–570.



Ginekologia i Perinatologia Praktyczna